Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
Phase of Trial: Phase III
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Insulin aspart (Primary) ; Insulin degludec
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms onset7
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 26 Jan 2017 Planned number of patients changed from 833 to 803.
- 26 Jul 2016 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.